"How do we know if our innovation function is actually working?"

It is one of the most common questions I hear from innovation leaders — and one of the least satisfactorily answered in most organisations. Revenue and profit are easy to measure. Innovation is not. The outputs are uncertain, the timelines are long, and the relationship between activity and outcome is rarely straightforward.

But "it is hard to measure" is not the same as "it cannot be measured." The problem is not that innovation metrics do not exist — it is that most organisations rely on too narrow a set of them, miss the ones that would tell them something useful, and then draw the wrong conclusions from the ones they do track.

Why Measuring Innovation Is Genuinely Difficult

Three things make innovation measurement harder than standard business performance measurement.

First, the definition of innovation keeps shifting. Without a shared definition, your metrics are measuring different things for different people.

Second, the lag between activity and outcome is long and variable. An experiment that produces no immediate revenue might be generating critical learning that shapes a successful product two years from now. Standard reporting cycles were designed for operational performance, not for the multi-year, non-linear arc of innovation.

Third, many of the most important signals in an innovation function are leading indicators — things that predict future performance — rather than lagging ones that confirm past results. Most organisations are set up to track lagging indicators, which means by the time the measurement shows a problem, months of potential course-correction time have already been lost.

A robust measurement approach needs all four of the perspectives below. No single one of them tells the full story.

The 4 Perspectives for Measuring Innovation

Result-Based Measures

Result-based measures track business outcomes: revenue generated by new products or services, profit contribution, market share gained, customer adoption rates. These are the metrics most familiar to senior leadership.

They are important — and they are insufficient on their own. The fundamental limitation is that they are lagging indicators. They tell you what happened, not what is happening or what is likely to happen next.

Useful KPIs

Revenue from new products or services · Gross margin on new offerings · Customer adoption rate · Market share in new categories · New revenue as a percentage of total revenue

Process Measures

Process measures track the health and activity of the innovation pipeline itself: how many ideas are being generated, how many are getting funded, how long it takes to move from concept to market, how many experiments are running at any given time.

These are the metrics most commonly overlooked by senior leadership because they do not show up in a P&L. And they are often the earliest warning signs that something in the innovation function is broken — long before the result metrics decline.

Useful KPIs

Number of ideas in pipeline · Number of ideas funded · Number of experiments running · Average time from idea to market launch · Number of concepts killed (a healthy pipeline kills things) · Percentage of ideas progressing to next stage

Project Measures

Project measures evaluate the performance of individual innovation initiatives: the return on investment from a specific project, customer satisfaction with a specific new product, sales generated by a specific new service.

This perspective is valuable because it creates accountability at the project level and generates the kind of specific, actionable insight that portfolio-level or function-level measurement cannot provide. The limitation is time horizon — initial project performance is not always a reliable indicator of innovation value.

Useful KPIs

ROI per project over time · Customer satisfaction scores (CSAT) · Net Promoter Score (NPS) on new products · Revenue per new product · Customer retention on new offerings

Portfolio Measures

Portfolio measures take the widest view — evaluating the innovation function's performance across all projects, over time, accounting for both the successes and the failures. This is the perspective that most accurately reflects the nature of innovation.

No innovation portfolio produces only winners. The honest expectation — one that leading venture capital funds have operated on for decades — is that a small number of bets will generate returns significant enough to offset the losses on the ones that do not work. Corporate innovation leaders need to think the same way.

Useful KPIs

Total portfolio ROI · Number of projects successfully commercialised · Portfolio diversification across horizon types (incremental, adjacent, transformational) · Hit rate over time · Total revenue attributable to portfolio across a defined period

Building Your Measurement Mix

No single KPI captures the health of an innovation function. The goal is a measurement mix that gives leadership visibility across all four perspectives — enough to understand current performance, diagnose problems early, and make resource allocation decisions with confidence.

A practical starting point: identify one or two KPIs from each of the four perspectives that are relevant to your organisation's current innovation strategy and that you can actually track with the data you have access to today. Do not build a measurement system around data you do not have yet. Start with what is tractable, build the habit of regular review, and add sophistication as the function matures.


When Measurement Reveals a Decision Problem

Sometimes measurement does its job well. The data is clear. The opportunity scores well across all the relevant dimensions. The pipeline is healthy. The signal is there. And still nobody makes a decision.

If that pattern sounds familiar, the problem is not measurement. You have enough information. What you are missing is a structured process for turning that information into a decision you can defend.

That is exactly what the Innovation Sprint is built for. Three weeks. A fixed-scope process that takes a clearly understood opportunity and produces a go, no-go, or pivot verdict — with a 90-day action plan your CFO can act on. Fixed fee. Guaranteed outcome.

If you want to talk through whether a Sprint is the right next step, book a free 30-minute call. And if you have not yet scored the specific opportunity sitting in your pipeline, our free Innovation Go/No-Go Scorecard takes twenty minutes and gives you a number you can defend.


Frequently Asked Questions

Innovation performance is best measured across four complementary perspectives: result-based measures (commercial outcomes like revenue and adoption), process measures (pipeline health and activity), project measures (performance of individual initiatives over time), and portfolio measures (aggregate performance across all innovation bets). No single metric captures the full picture.

A practical starting set: revenue from new products or services (result), number of experiments running and average time to market (process), NPS and ROI per new product (project), and total portfolio ROI and commercialisation rate (portfolio). Track at least one KPI from each perspective to avoid a measurement system that only tells part of the story.

Three factors make it genuinely hard: the timeline between innovation activity and commercial outcome is long (often two to five years); many important innovation metrics are leading indicators while most organisations track lagging indicators; and without a shared definition of innovation, different stakeholders are effectively measuring different things.

Result measures track commercial outcomes — revenue, profit, market share. They are lagging indicators: they tell you what happened. Process measures track pipeline health and activity — ideas generated, experiments running, time to market — before commercial outcomes are known. They are leading indicators: they tell you what is likely to happen.

A portfolio approach evaluates innovation performance across all projects collectively, rather than judging each initiative in isolation. It recognises that innovation, like venture capital investing, produces a distribution of outcomes — most bets will not generate significant returns, but a small number of successes should more than offset the losses.